Although elevated expression of ECT2 in breast cancer has been reported 34 and ECT2 is linked to dissemination and metastasis of breast cancer cells via controlling RhoA and CDC42 24, 35, it remains obscure whether nuclear GEF-independent activity of ECT2 also plays a role in the progression and development of breast cancer. Here, CDC42 is linked to breast cancer.